Anti-LKM antibody

From WikiMD's WELLNESSPEDIA

Anti-LKM antibody is a type of autoantibody that is primarily associated with autoimmune hepatitis and lupus. It is one of the serological markers used in the diagnosis of these conditions.

Overview[edit]

Anti-LKM antibodies are directed against liver and kidney microsomes. They are found in a subset of patients with autoimmune hepatitis, particularly those with a form of the disease known as type 2 autoimmune hepatitis. These antibodies are also found in a small percentage of patients with lupus.

Clinical significance[edit]

The presence of Anti-LKM antibodies in the blood is a significant finding in the diagnosis of autoimmune hepatitis. They are not found in healthy individuals and their presence indicates an autoimmune process is occurring.

In addition to their role in diagnosis, Anti-LKM antibodies may also have a role in the pathogenesis of autoimmune hepatitis. It is thought that these antibodies may contribute to the liver damage seen in this condition by attacking the liver cells.

Diagnosis[edit]

The detection of Anti-LKM antibodies is typically done through a blood test. This test is often part of a larger panel of tests used to diagnose autoimmune hepatitis.

Treatment[edit]

The treatment for conditions associated with Anti-LKM antibodies typically involves managing the underlying autoimmune condition. This often involves the use of medications to suppress the immune system and reduce inflammation.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.